Commodore Capital LP Centessa Pharmaceuticals PLC Transaction History
Commodore Capital LP
- $1.02 Billion
- Q1 2025
A detailed history of Commodore Capital LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Commodore Capital LP holds 2,367,578 shares of CNTA stock, worth $40.3 Million. This represents 3.33% of its overall portfolio holdings.
Number of Shares
2,367,578
Previous 2,218,425
6.72%
Holding current value
$40.3 Million
Previous $37.2 Million
8.38%
% of portfolio
3.33%
Previous 3.72%
Shares
3 transactions
Others Institutions Holding CNTA
# of Institutions
136Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$340 Million74.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$170 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$165 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$118 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$101 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.61B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...